About This Deal

PLEXUS CORP acquired SeaMED Corporation for Stock merger; Plexus issued approximately 2,265,822 shares of common stock (0.4-for-1 exchange ratio) plus assumed options for ~171,804 shares, a transaction completed in July 1999, structured as all stock (pooling of interests).

SeaMED Corporation operates in Medical electronics design & manufacturing services, is based in Bothell, Washington (Seattle area), United States. SeaMED Corporation of Bothell, Washington, which designs and manufactures advanced durable electronic medical instruments for established and emerging medical technology companies, combining engineering, manufacturing and regulatory expertise to develop and commercialize advanced medical instruments. SeaMED merged with a wholly-owned subsidiary of Plexus and became a wholly-owned subsidiary.

Added SeaMED's medical engineering and regulatory knowledge and complex higher-level assembly capabilities to Plexus's product realization services.

Medical engineering and regulatory knowledge plus complex higher-level assembly capabilities that broadened Plexus's design and manufacturing services. Became a wholly-owned subsidiary of Plexus; ~162,000 sq ft and ~301 employees in Bothell, Washington at acquisition date

Deal Terms

Acquirer
PLEXUS CORP
Target
SeaMED Corporation
Value
Stock merger; Plexus issued approximately 2,265,822 shares of common stock (0.4-for-1 exchange ratio) plus assumed options for ~171,804 shares
Date
July 1999
Type
Merger (acquisition)
Status
Ready

Transaction Details

Target HQ
Bothell, Washington (Seattle area), United States
Segment
Medical electronics design & manufacturing services
Structure
all stock (pooling of interests)
Announced
March 16, 1999
Closed
July 23, 1999

In Their Words

SeaMED designs and manufactures advanced durable electronic medical instruments for both established and emerging medical technology companies. With its combination of engineering, manufacturing and regulatory expertise, SeaMED provides integrated solutions to the challenges of developing and commercializing advanced medical instruments.Plexus Corp Form 8-K (period of report July 23, 1999), Item 2

Advisors

Advisory firms were not disclosed for this transaction.

Related Deals & Entities

Sources: Press release ↗ · Last updated June 19, 2026

See how VectorShift works for your firm

Request Demo